Meg Helms is Founder and President of Morgan Wallace Associates, LLC, a global strategic healthcare M&A consulting firm. In a variety of transaction-based assignments during her 31 year career with Johnson & Johnson (J&J), Meg successfully closed dozens of M&A transactions with deal values of up to $500 million. These included in and out-licensing agreements, privately and publicly held acquisitions, divestitures, co-development agreements, distribution, supply and licensing agreements and equity investments in start-up companies. She is particularly skilled in handling global transactions, most recently in Israel and China, and successfully completed many other transactions in Western Europe, Asia Pacific and the US. While at J&J, Meg held positions with increasing responsibility in marketing and business development roles across all three sectors (medical device & diagnostics, pharmaceutical and consumer) and contributed to cumulative revenues of over $500 million via her BD deals. She also developed multiple strategic assessments, launched products and served on Business Unit boards in her capacity as Worldwide Director for over 11 years.
Meg holds an MBA from Washington University – St. Louis, and a BA from Rutgers University (Douglas College), New Brunswick, NJ. She is a member of BioNJ, Licensing Executives Society (LES), Healthcare Businesswomen’s Association (HBA) and Women’s Business Leaders in Healthcare (WBL). Meg is also very active in not – for – profit organizations, currently serving on the Boards of the Carrier Clinic, Raritan Valley Habitat for Humanity and the HBA’s Metro Chapter, an active member of the Princeton Chamber of Commerce Women in Business Alliance’s (WIBA) steering committee, and served as a mentor the HBA’s group mentoring program for 3 years.